In silico exploration for identifying structure-activity relationship of MEK inhibition and oral bioavailability for isothiazole derivatives.
about
Advances in computationally modeling human oral bioavailabilityCheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).Curated human hyperbilirubinemia data and the respective OATP1B1 and 1B3 inhibition predictionsScreening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics.Structure based classification for bile salt export pump (BSEP) inhibitors using comparative structural modeling of human BSEP.Searching for anthranilic acid-based thumb pocket 2 HCV NS5B polymerase inhibitors through a combination of molecular docking, 3D-QSAR and virtual screening.Predicting Drug-Induced Cholestasis with the Help of Hepatic Transporters-An in Silico Modeling Approach.Correlation between in silico physicochemical characteristics of drugs and their mean residence time in human and dog.An automated framework for QSAR model building.Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles
P2860
Q27008316-B4A15F94-0F60-4B89-903D-B85821B54632Q33584492-34CE6F45-389F-4E33-A26C-A90405FC2C10Q36292622-0794F7BB-29C1-40A7-88CF-6160CF639EEDQ40730284-0857B2E3-1923-460A-9EB1-8C016EC422A4Q41022676-2698BEA5-A361-4372-B05B-1701D28B8D04Q41681901-68806D52-6FD0-4A4C-9166-5936401881D9Q42290083-D62105D1-A47B-4FC7-B45C-09DA3209F479Q46621575-A71C8124-7702-4C0C-B143-3FB41F5CB533Q48230351-C2E40C67-1E26-4133-A9D0-71363E4F4B99Q57008609-44FCB161-E21C-43BF-B547-B1FC949A8924
P2860
In silico exploration for identifying structure-activity relationship of MEK inhibition and oral bioavailability for isothiazole derivatives.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
In silico exploration for iden ...... y for isothiazole derivatives.
@en
In silico exploration for iden ...... y for isothiazole derivatives.
@nl
type
label
In silico exploration for iden ...... y for isothiazole derivatives.
@en
In silico exploration for iden ...... y for isothiazole derivatives.
@nl
prefLabel
In silico exploration for iden ...... y for isothiazole derivatives.
@en
In silico exploration for iden ...... y for isothiazole derivatives.
@nl
P50
P1476
In silico exploration for iden ...... y for isothiazole derivatives.
@en
P2093
Olga Igglessi-Markopoulou
P2860
P304
P356
10.1111/J.1747-0285.2010.01029.X
P577
2010-11-01T00:00:00Z